EMA Authorised: Tybost (cobicistat) — Gilead Sciences Ireland UC

View source ↗

Summary

Authorisation of Tybost (cobicistat) by EMA for use in HIV infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tybost (Cobicistat)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: Gilead Sciences Ireland UC. Decision date: 13/02/2023